Report cover image

U.S. Premium Bottled Water Market Size, Share, Trend, Industry Analysis Report By Product (Spring Water, Sparkling Water, Mineral Water, Others), By Distribution Channel – Market Forecast, 2025–2034

Published Sep 01, 2025
Length 123 Pages
SKU # PLRS20451398

Description

The U.S. premium bottled water market size is expected to reach USD 12.31 billion by 2034, according to a new study by Polaris Market Research. The report “U.S. Premium Bottled Water Market Size, Share, Trend, Industry Analysis Report By Product (Spring Water, Sparkling Water, Mineral Water, Others), By Distribution Channel – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The U.S. premium bottled water market refers to the segment of bottled water positioned as a higher-value product, often distinguished by superior quality, unique sourcing, advanced purification processes, or added health and lifestyle benefits. This market caters to consumers who prioritize taste, purity, brand reputation, and perceived health advantages over standard bottled water options. Growth is fueled by rising health consciousness, where consumers increasingly prefer low-calorie, sugar-free beverages, and by a shift toward functional hydration, including mineral-rich and electrolyte-enhanced offerings. The influence of lifestyle marketing and luxury positioning has also created strong demand, supported by packaging innovations that emphasize sustainability and aesthetics. Increasing interest in natural and sustainably sourced water, combined with transparency in sourcing and production, continues to elevate consumer trust and brand loyalty.

Digital marketing and direct-to-consumer strategies are enabling niche premium brands to reach targeted audiences effectively. The market is also benefiting from demand for on-the-go hydration in urban and active lifestyles, aligning with trends in convenience and wellness. Opportunities lie in expanding premium functional water offerings, introducing eco-friendly packaging solutions, and integrating traceability technologies to meet growing consumer demand for authenticity. Brands that can blend luxury appeal with environmental responsibility and functional benefits are well-positioned to capture long-term market growth.

U.S. Premium Bottled Water Market Report Highlights

By product, the mineral water segment accounted for the largest revenue share of ~41% in 2024 due to its strong positioning as a naturally sourced, nutrient-rich hydration option favored by health-conscious consumers.

Based on distribution channel, the supermarkets & hypermarkets segment held the largest revenue share of ~38% in 2024, driven by their ability to offer diverse premium bottled water selections under one roof, catering to varied consumer tastes.

A few key players include Acqua Panna; CORE Nutrition LLC; Danone Waters of America (Evian); FIJI Water Company LLC; Flow Hydration; Icelandic Glacial, Inc.; Perrier International; Sanpellegrino S.p.A.; The Coca Cola Company; and Voss USA, Inc.

Polaris Market Research has segmented the U.S. premium bottled water market report on the basis of product and distribution channel:

By Product Outlook (Revenue, USD Billion, 2020–2034)

Spring Water

Sparkling Water

Mineral Water

Others

By Distribution Channel Outlook (Revenue, USD Billion, 2020–2034)

Supermarkets & Hypermarkets

Specialty Stores

Online

Others

Table of Contents

123 Pages
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. U.S. Neurovascular Intervention Devices Market Insights
4.1. U.S. Neurovascular Intervention Devices Market – Market Snapshot
4.2. U.S. Neurovascular Intervention Devices Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Rising Prevalence of Neurovascular Diseases
4.2.1.2. Aging Population Increasing Prevalence of Cerebrovascular Disorders
4.2.2. Restraints and Challenges
4.2.2.1. High Device Costs and Procedural Complexity
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. U.S. Neurovascular Intervention Devices Market Trends
4.6. Value Chain Analysis
5. U.S. Neurovascular Intervention Devices Market, by Product
5.1. Key Findings
5.2. Introduction
5.2.1. U.S. Neurovascular Intervention Devices Market, by Product, 2020-2034 (USD Billion)
5.3. Embolic Coils
5.3.1. U.S. Neurovascular Intervention Devices Market, by Embolic Coils, by Country, 2020-2034 (USD Billion)
5.4. Carotid Stents
5.4.1. U.S. Neurovascular Intervention Devices Market, by Carotid Stents, by Country, 2020-2034 (USD Billion)
5.5. Intracranial Stents
5.5.1. U.S. Neurovascular Intervention Devices Market, by Intracranial Stents, by Country, 2020-2034 (USD Billion)
5.6. Neurovascular Thrombectomy
5.6.1. U.S. Neurovascular Intervention Devices Market, by Neurovascular Thrombectomy, by Country, 2020-2034 (USD Billion)
5.7. Embolic Protection Devices
5.7.1. U.S. Neurovascular Intervention Devices Market, by Embolic Protection Devices, by Country, 2020-2034 (USD Billion)
5.8. Flow Diverters Devices
5.8.1. U.S. Neurovascular Intervention Devices Market, by Flow Diverters Devices, by Country, 2020-2034 (USD Billion)
5.9. Intrasaccular Devices
5.9.1. U.S. Neurovascular Intervention Devices Market, by Intrasaccular Devices, by Country, 2020-2034 (USD Billion)
5.10. Liquid Embolic
5.10.1. U.S. Neurovascular Intervention Devices Market, by Liquid Embolic, by Country, 2020-2034 (USD Billion)
5.11. Balloons
5.11.1. U.S. Neurovascular Intervention Devices Market, by Balloons, by Country, 2020-2034 (USD Billion)
5.12. Stent Retrievers
5.12.1. U.S. Neurovascular Intervention Devices Market, by Stent Retrievers, by Country, 2020-2034 (USD Billion)
6. U.S. Neurovascular Intervention Devices Market, by Technique
6.1. Key Findings
6.2. Introduction
6.2.1. U.S. Neurovascular Intervention Devices Market, by Technique, 2020-2034 (USD Billion)
6.3. Neurothrombectomy Procedure
6.3.1. U.S. Neurovascular Intervention Devices Market, by Neurothrombectomy Procedure, by Country, 2020-2034 (USD Billion)
6.4. Cerebral Angiography
6.4.1. U.S. Neurovascular Intervention Devices Market, by Cerebral Angiography, by Country, 2020-2034 (USD Billion)
6.5. Stenting
6.5.1. U.S. Neurovascular Intervention Devices Market, by Stenting, by Country, 2020-2034 (USD Billion)
6.6. Coiling Procedures
6.6.1. U.S. Neurovascular Intervention Devices Market, by Coiling Procedures, by Country, 2020-2034 (USD Billion)
6.7. Flow Disruption
6.7.1. U.S. Neurovascular Intervention Devices Market, by Flow Disruption, by Country, 2020-2034 (USD Billion)
7. U.S. Neurovascular Intervention Devices Market, by End User
7.1. Key Findings
7.2. Introduction
7.2.1. U.S. Neurovascular Intervention Devices Market, by End User, 2020-2034 (USD Billion)
7.3. Hospitals
7.3.1. U.S. Neurovascular Intervention Devices Market, by Hospitals, by Country, 2020-2034 (USD Billion)
7.4. Ambulatory Surgical Centers
7.4.1. U.S. Neurovascular Intervention Devices Market, by Ambulatory Surgical Centers, by Country, 2020-2034 (USD Billion)
7.5. Other End Users
7.5.1. U.S. Neurovascular Intervention Devices Market, by Other End Users, by Country, 2020-2034 (USD Billion)
8. U.S. Neurovascular Intervention Devices Market, by Country
8.1. Key Findings
8.2. Introduction
8.2.1. U.S. Neurovascular Intervention Devices Market Assessment, By Country, 2020-2034 (USD Billion)
8.2.2. U.S. Neurovascular Intervention Devices Market
8.2.2.1. U.S.: Neurovascular Intervention Devices Market, by Product, 2020-2034 (USD Billion)
8.2.2.2. U.S.: Neurovascular Intervention Devices Market, by Technique, 2020-2034 (USD Billion)
8.2.2.3. U.S.: Neurovascular Intervention Devices Market, by End User, 2020-2034 (USD Billion)
9. Competitive Landscape
9.1. Expansion and Acquisition Analysis
9.1.1. Expansion
9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
10.1. Abbott Laboratories
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Recent Development
10.2. Acandis GmbH
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Benchmarking
10.2.4. Recent Development
10.3. Balt USA
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Benchmarking
10.3.4. Recent Development
10.4. Inari Medical
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Benchmarking
10.4.4. Recent Development
10.5. Johnson & Johnson
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Benchmarking
10.5.4. Recent Development
10.6. Medtronic plc
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Benchmarking
10.6.4. Recent Development
10.7. Rapid Medical
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Benchmarking
10.7.4. Recent Development
10.8. Stryker Corporation
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product Benchmarking
10.8.4. Recent Development
10.9. Terumo Corporation
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product Benchmarking
10.9.4. Recent Development
10.10. VESALIO
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Product Benchmarking
10.10.4. Recent Development
10.11. Zeta Surgical
10.11.1. Company Overview
10.11.2. Financial Performance
10.11.3. Product Benchmarking
10.11.4. Recent Development
10.12. Penumbra
10.12.1. Company Overview
10.12.2. Financial Performance
10.12.3. Product Benchmarking
10.12.4. Recent Development
10.13. Q’Apel Medical, Inc.
10.13.1. Company Overview
10.13.2. Financial Performance
10.13.3. Product Benchmarking
10.13.4. Recent Development
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.